Interaction of anticancer drug methotrexate with nucleic acids analyzed by multi-spectroscopic method

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy

Volumn 72, Issue 1, 2009, Pages 46-49

  Cai, Changqun ^a   Chen, Xiaoming ^a   Gong, Hang ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

1H NMR spectra; Cetyltrimethylammonium bromide (CTMAB); Methotrexate; Nucleic acids; Resonance light scattering (RLS) spectrum; UV vis

Indexed keywords

1H NMR SPECTRA; CETYLTRIMETHYLAMMONIUM BROMIDE (CTMAB); METHOTREXATE; RESONANCE LIGHT SCATTERING (RLS) SPECTRUM; UV-VIS;

AMMONIUM COMPOUNDS; ANIMAL CELL CULTURE; BIOMOLECULES; CATIONIC SURFACTANTS; DRUG INTERACTIONS; DYES; FLOW INTERACTIONS; LIGHT SCATTERING; NUCLEAR MAGNETIC RESONANCE; NUCLEIC ACIDS; ORGANIC ACIDS; REFRACTION; RESONANCE; SCATTERING; SURFACE ACTIVE AGENTS;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTINEOPLASTIC AGENT; BUFFER; CETRIMIDE; METHOTREXATE; NUCLEIC ACID; SURFACTANT;

ARTICLE; CHEMISTRY; LIGHT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOLARITY; RADIATION SCATTERING; SPECTROFLUOROMETRY; SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; BUFFERS; CETRIMONIUM COMPOUNDS; LIGHT; MAGNETIC RESONANCE SPECTROSCOPY; METHOTREXATE; NUCLEIC ACIDS; OSMOLAR CONCENTRATION; SCATTERING, RADIATION; SPECTROMETRY, FLUORESCENCE; SPECTRUM ANALYSIS; SURFACE-ACTIVE AGENTS;

EID: 57949105118     PISSN: 13861425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.saa.2008.07.022     Document Type: Article

References (19)

1. Katzung B.G. Basic and Clinical Pharmacology. eighth ed. (2000), Lange Medical Books/McGraw-Hill p. 931
2. Ackland S.P., and Schilsky R.L. J. Clin. Oncol. 5 (1987) 2017-2031
3. Goulian M., Bleile B., and Tseng B.Y. Proc. Acad. Sci. U.S.A. 77 (1980) 1956
4. Bleyer W.A. Cancer 41 (1978) 36
5. Parfitt K., Sweetman S.C., Blake P.S., and Parsons A.V. Martindale the Extra Pharmacopoeia. 32th ed. (1999), Pharmaceutical Press, London p. 547
6. De Porcer-Morton C., Vhuang J., Specker M., and Bas-tian R. Performance Evaluation of EMIT Methotrexate As-say (1978), Syva, Palo Alto
7. Pesce M.A., and Bodourian S.H. Ther. Drug. Monit. 8 (1986) 115-121
8. Raso V., and Schereider R. Cancer Res. 35 (1975) 1407-1410
9. Roach M.C., Gozel P., and Zare R.N. J. Chromatogr., Biomed. Appl. 426 (1988) 129-140
10. Beck O., Seideman P., Wennberg M., and Peterson C. Ther. Drug. Monit. 13 (1991) 528-532
11. Mader R.M., Rizouski B., Steger G.G., and Rainer H. J. Chromatogr. B 613 (1993) 311-316
12. Lu G., and Jun H.W. J. Liquid Chromatogr. 18 (1995) 155
13. Chen Z., Liu J., and Luo D. Biochemistry Experiments (1994), Chinese University of Sciences and Technology Press, Hefei, China
14. Liu R.T., Yang J.H., Wu X., and Wu T. Anal. Chim. Acta 448 (2001) 85-91
15. William W.L., Carlos U., and Elliot V.N. Circ. Res. 3 6 (1955) 570-574
16. Pasternack R.F., and Collings P.J. Science 269 5226 (1995) 935-939
17. Huang C.Z., Li Y.F., and Liu X.D. Anal. Chem. Acta 375 1-2 (1998) 89-97
18. Collins F.S., Patrinos A., Jordan E., Chakravi A., Gesteland R., and Walters L. Science 282 5389 (1998) 682-689
19. Odani A., Deguchi S., and Yamauchi O. J. Inorg Chem 25 1 (1986) 62-69